ERBB2 and cancer: In addition to autophagy, CBZ modulates proteasomal protein degradation: a study on the breast cancer protein Her-2 found that CBZ increases acetylation of Hsp90, which then lessens the ability of Hsp90 to interact with Her-2 [92].